Thompson Siegel & Walmsley’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.74M Sell
266,682
-156,795
-37% -$3.71M 0.12% 192
2026
Q1
$9.25M Buy
423,477
+45,993
+12% +$1.07M 0.16% 135
2025
Q4
$8.78M Buy
377,484
+137,245
+57% +$3.31M 0.15% 151
2025
Q3
$6.8M Sell
240,239
-157,122
-40% -$4.17M 0.11% 181
2025
Q2
$8.74M Buy
397,361
+61,089
+18% +$1.34M 0.15% 143
2025
Q1
$7.83M Buy
+336,272
New +$8.6M 0.13% 146
2017
Q4
– Sell
-1,802
Closed -$36K – 848
2017
Q3
$36K Hold
1,802
– – ﹤0.01% 571
2017
Q2
$34K Buy
+1,802
New +$35.1K ﹤0.01% 590

Other funds holding GNTX

Thompson Siegel & Walmsley's GNTX Position: Q2 2026 in Review

Thompson Siegel & Walmsley reduced its Gentex (GNTX) stake by 37% in Q2 2026, selling an estimated $3.71M and leaving 266,682 shares worth $6.74M. The position accounts for 0.12% of the portfolio, ranked #192.

Thompson Siegel & Walmsley first reported a position in GNTX in Q2 2017 and has held it in 8 quarters since. The position peaked at $9.25M in Q1 2026. 532 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Thompson Siegel & Walmsley held 266,682 shares of Gentex worth $6.74M as of Q2 2026.
  • Thompson Siegel & Walmsley sold 156,795 Gentex shares in Q2 2026, an estimated $3.71M.
  • Gentex made up 0.12% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #192 holding.
  • Thompson Siegel & Walmsley first reported a position in Gentex in Q2 2017 and has held it in 8 quarters since.
  • Thompson Siegel & Walmsley's Gentex position peaked at $9.25M in Q1 2026.
  • 532 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.